July is Dry Eye Awareness month, and there is a lot of which to be aware! There are so many new diagnostics and treatments in dry eye disease today compared to a few years ago, it is simply amazing. Many of these options can be extended to contact lens wearers, so please check out our July issue of Contact Lens Spectrum for the latest and greatest in dry eye disease. One significant topic for discussion is the role that osmolarity plays in dry eye. Please send us your thoughts on the topic, and we will summarize and share them over the next few weeks. You can reach us at firstname.lastname@example.org.
Jason J. Nichols, OD, MPH, PhD
Visioneering Technologies Appoints Several Territory Managers
Visioneering Technologies, Inc. (VTI) announced that Michelle Kirst has joined the company as territory manager for New Jersey. Before joining VTI, she was with Essilor USA, where she held positions as sales and marketing manager consultant and account manager.
VTI also announced that Ron Makelke has joined the company as territory manager for San Francisco. He has more than 15 years of experience in account management. He spent seven years working with a large Bay Area independent laboratory. He has also previously held positions with Empire Optical; CSC Labs; Perfect Optics; Briot USA, Inc.; Empire Labs; and FGX International, an Essilor company.
Finally, VTI announced that Connie Stewart has joined the company as territory manager for Los Angeles. Her four decades of sales experience includes territory sales manager for Hoya Vision Care as well as area sales manager for Pixel Optics. Stewart also worked as a sales consultant with Essilor Lenses and Essilor Laboratories.
All three of them will be responsible for introducing eyecare practitioners and practices across the state to the patented technology of the NaturalVue (etafilcon A) Multifocal 1 Day Contact Lenses as well as other NaturalVue Brand products.
American Academy of Optometry Announces 2017 Award Recipients
Each year, the American Academy of Optometry recognizes distinguished individuals who have made countless contributions to advancing the profession of optometry.
The 2017 award winners are: Eli Peli, MSc, OD – Charles F. Prentice Medal and Lecture Award Mitchell Scheiman, OD, PhD – Glenn A. Fry Award and Lecture (American Academy of Optometry Foundation Award) Ava K. Bittner, OD, PhD – Irvin M. and Beatrice Borish Award Luigi Bilotto, MS, OD – AAO-Essilor Award for Outstanding International Contributions to Optometry C. Ellis Potter, OD – Brien Holden Humanitarian Award Joseph Fontenot, MD, CLVT – Carel C. Koch Memorial Medal Award Laura Goldberg, OD, MS; Celia R. Gong – Julius F. Neumueller Award in Optics (American Academy of Optometry Foundation Award) Richard Madonna, MA, OD – Vincent Ellerbrock Clinician Educator Award Harue J. Marsden, OD, MS– (posthumously) Eminent Service Award Bert C. Corwin, OD; Avrum Richler, OD, PhD – Life Fellow Award Jeffrey J. Walline, OD, PhD; Katie L. Greiner, OD, MS; Mary Elizabeth McVey, OD, MS; and Lisa A. Jones-Jordan, PhD – Garland W. Clay Award Lorraine Lombardi, PhD – Michael G. Harris Award for Excellence in Optometric Education (American Academy of Optometry Foundation Award)
The awards of the Section on Cornea, Contact Lenses & Refractive Technologies include: Suzanne M.J. Fleiszig, OD, PhD – Max Schapero Memorial Lecture Award Lynette Johns, OD, FSLS – Founders’ Award
Award winners will be recognized at the Academy 2017 Chicago Awards Ceremony on Oct. 13. Section on Cornea, Contact Lenses and Refractive Technologies award recipients will be honored on Oct. 11.
AAOF Announces 2017 Joseph T. Barr Early Cornea And Contact Lens Inaugural Research Award Recipient
Yuno Iwabuchi, a fourth-year OD/MS student and teaching assistant at Pacific University College of Optometry, was chosen by a committee of members in the Cornea, Contact Lenses and Refractive Technologies section of the American Academy of Optometry as this year’s inaugural recipient for the Joseph T. Barr Early Cornea and Contact Lens Research Award.
The award is intended to provide MS, PhD, vision science, or physiological optics students attending a school or college of optometry in North America with research seed funding for a project in cornea/ocular surface or contact lenses.
Of the five applicants who applied to the program, Ms. Iwabuchi presented an impressive resume of experience in clinical, volunteer service, research, and lecture presentation. She will receive a $2,000 education award and a $750 travel fellowship to attend the Academy 2017 Chicago annual meeting in October.
Call for Papers and Posters – GSLS 2018
The Educational Program Committee of the Global Specialty Lens Symposium invites the submission of abstracts for the Free Paper Section and the Scientific Poster Competition. Papers and posters related to presbyopia, keratoconus, corneal topography, post-penetrating keratoplasty or related irregular corneal surface, myopia control, orthokeratology, and lens care topics are welcome.
This image shows an atypical presentation of Terrien’s marginal degeneration in a 37-year-old female who presented to the clinic with complaints of decreased vision in her left eye.
We thank Dr. Liao for this image and welcome photo submissions from our other readers! It is easy to submit a photo for consideration for publishing in Contact Lenses Today. Simply visit http://www.cltoday.com/upload/upload.aspx to upload your image. Please include a detailed explanation of the photo and your full name, degree or title, and city/state/country.
S. Barry Eiden, OD
The Use of Contact Lenses as Part of a Low Vision Rehabilitation Program for Vision Loss Due to Congenital Eye Diseases
According to an article recently published in Clinical and Experimental Optometry,1 ocular pathology that manifests at an early age has the potential to alter the vision-dependent emmetropization mechanism, which coordinates ocular growth throughout childhood. The disruption of this feedback mechanism in children who have congenital or early-onset visual impairment often results in the development of significant ametropia, including high levels of spherical refractive error, astigmatism, and anisometropia.
The authors performed a review of the use of contact lenses as a refractive correction, low vision aid, and therapeutic intervention in the rehabilitation of patients who have bilateral, irreversible visual loss due to congenital ocular disease. The advantages and disadvantages of the use of contact lenses for increased magnification (telescopes and microscopes) or field expansion (reverse telescopes) are discussed, along with the benefits and practical considerations for the correction of pathological high myopia. The historical and present use of therapeutic tinted contact lenses to reduce photosensitivity and nystagmus in achromatopsia, albinism, and aniridia are also presented.
In addition to the known optical benefits in comparison to spectacles for high levels of ametropia (an improved field of view for myopes and fewer inherent oblique aberrations), the authors stated that contact lenses may be of significant psychosocial benefit for patients who have low vision due to enhanced cosmesis, reduced conspicuity, and potential related effects of improved self-esteem and peer acceptance. The authors concluded that contact lens correction of patients who have congenital vision impairment can be challenging for both practitioners and patients, but contact lenses should be considered as a potential optical or therapeutic solution in modern low vision rehabilitation.
We are faced with a multitude of clinical challenges on a daily basis. Management of congenital eye disease and associated vision loss can be one of the most rewarding in terms of the impact we can have on an individual’s entire life. Application of contact lens technologies for these patients should always be considered and applied if appropriate. Here is but another example of how contact lens practice can be taken outside of the “off-the-shelf box of lenses” and put squarely back in the hands of skilled and experienced contact lens practitioners.
1. Vincent SJ. The use of contact lenses in low vision rehabilitation: optical and therapeutic applications. Clin Exp Optom. 2017 Jun 29. [Epub ahead of print]
OCULAR SURFACE UPDATE
Katherine M. Mastrota, MS, OD
How Does It Feel?
Some of my favorite patients have become real friends. One example is my friend Michael, whom I have known for more than 10 years.
Michael is a super-smart and engaging young attorney who is interested in many of the same things that I am. One topic of our conversation is the management of his glaucoma (which is quite advanced in one eye) and his dry eye. Michael’s dry eye has been exacerbated by the glaucoma drops that he diligently uses daily. He has been on every class of glaucoma medication, has had multiple selective laser trabeculoplasties, and two trabeculectomies in the eye with worse disease.
Now with stable, low intraocular pressure in the post-trab eye, he uses no glaucoma medications. In his fellow eye, he is on a combination medication and a prostaglandin analog. He uses cyclosporine twice a day in both eyes.
Over dinner, I queried Michael about how each eye felt. In light of two surgeries and years of glaucoma medication in the worse eye, I wondered whether he could perceive a difference in the way each eye felt. I wasn’t certain whether the eye that had undergone two trabs (and had a bleb) would feel more or less comfortable compared to the eye receiving multiple eye medications.
Growth of Meibomian Gland Tissue After Intraductal Meibomian Gland Probing in Patients with Obstructive Meibomian Gland Dysfunction
The purpose of this study was to investigate the impact of meibomian gland probing (MGP) on the meibomian gland (MG) area from the upper lids of patients who have obstructive meibomian gland dysfunction (o-MGD). It was a retrospective study that compared pre-MGP/post-MGP non-contact infrared meibography results in patients who have o-MGD, viewing signs of MG growth within the total measurement field.
Post-MGP meibography of 34 lids (19 patients, ≥ 4.5 to ≤ 12 months’ follow up) showed 41.2% with MG growth. Ten lids had meibographies suitable for analysis, showing a significant collective (116 glands) increase in mean individual glandular area (MIGA) of 4.87% (p = 0.0145). Four of 10 lids independently showed a significant increase in MIGA, ranging from 10.70% to 21.13% (p < 0.0001, p = 0.0277, p = 0.0292, p = 0.0345), while six did not. At > 12 and < 25 months’ follow up, in 16 lids (nine additional patients), 25% had signs of MG growth. Analysis of three lids showed a significant collective (33 glands) increase in MIGA of 11.19% (p = 0.0004). Two of three lids independently showed a significant increase in MIGA of 13.73% and 20.00% (p = 0.0097, p = 0.0001). Collectively, for all 13 analyzed lids (149 glands), there was a significant increase of 6.38% in total glandular area (p = 0.0447) and a significant increase of 6.23% in MIGA (p = 0.0003).
The authors concluded that MGP was associated with increased MG tissue area and growth of atrophied MGs as viewed on meibography. MGP provides unequivocal physical proof of a patent meibum outflow tract through the natural orifice and may promote glandular growth in part by direct mechanical establishment of a patent duct/orifice system.
Maskin SL, Testa WR. Growth of meibomian gland tissue after intraductal meibomian gland probing in patients with obstructive meibomian gland dysfunction. Br J Ophthalmol. 2017 Jun 7. [Epub ahead of print]